MedTrace Logo

Preliminary Experience of Routine Voriconazole Therapeutic Drug Monitoring (TDM) in a Tertiary Care Centre

NCT01418833 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2015-02-09

No results posted yet for this study

Summary

The first goal of this study is to map all the subtherapeutic, therapeutic and supratherapeutic voriconazole plasma levels in the University Hospitals Leuven. The second objective is to optimize and validate guidelines for dose modifications in patients with too low or high plasma concentrations and to investigate if the same guidelines can be used in different patient populations.

Conditions

  • Patients Treated With Voriconazole

Sponsors & Collaborators

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

  • Kim Vanstraelen, R.Ph. · Catholic University of Leuven, Faculty of Pharmacy, division Hospital Pharmacy

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01418833 on ClinicalTrials.gov